Print

Ex-Sanofi (France) (SAN.PA) Rep Excluded From Healthcare Programs for Sample Scheme  
8/21/2013 7:53:43 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Last December, Sanofi agreed to pay $109 million to resolve kickback charges that free samples of its Hyalgan injectable knee medication were used to induce physicians to prescribe the treatment. Basically, Sanofi reps doled out extra samples that doctors would use to lower their average purchase costs and then make a profit by overbilling Medicare and Medicaid, among other programs.

Help employers find you! Check out all the jobs and post your resume.

//-->